Federated Hermes Premier Municipal Income Fund declares dividend
PITTSBURGH, March 10, 2022 /PRNewswire/ -- Federated Hermes Premier Municipal Income Fund (NYSE: FMN) has declared a dividend. The fund seeks to provide investors with current dividend income that is exempt from regular federal income tax. In addition, this fund features income exempt from the federal alternative minimum tax (AMT).
Tax-Free Dividend Per Share | ||
Record Date: | March 23, 2022 | |
Ex-Dividend Date: | March 22, 2022 | |
Payable Date: | April 1, 2022 | |
Amount | Change From Previous Month | |
$0.054 | $ -- | |
Investors can view additional portfolio information in the Products section of FederatedInvestors.com.
Federated Hermes, Inc. (NYSE: FHI)Ā is a global leader in active, responsible investment management, with $668.9 billion in assets under management. We deliver investment solutions that help investors target a broad range of outcomes and provide equity, fixed-income, alternative/private markets, multi-asset and liquidity management strategies to more than 11,000 institutions and intermediaries worldwide. Our clients include corporations, government entities, insurance companies, foundations and endowments, banks and broker/dealers. At Federated Hermes, responsibility is central to our client relationships, our long-term perspective and our fiduciary mindset. It's part of our heritage and the foundation of our future. Headquartered in Pittsburgh, Federated Hermes has nearly 2,000 employees in London, New York, Boston and offices worldwide. For more information, visit FederatedHermes.com.
###
View original content:https://www.prnewswire.com/news-releases/federated-hermes-premier-municipal-income-fund-declares-dividend-301500183.html
SOURCE Federated Hermes, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Signia Introduces MaX, Powered by Acoustic Intelligenceā¢: World's First AI Hearing Aid Platform with 4 DNNs
- The 2nd TMElive International Music Awards concluded, bringing together 34 Chinese and international acts to deliver a phenomenal global music celebration
- Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share